Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of bezafibrate in primary biliary cirrhosis: a pilot study.

× No keyword cloud information.

15 in total

1. Long-term effect of bezafibrate on parameters of hepatic fibrosis in primary biliary cirrhosis.

Authors: Kenji Ohmoto; Naoko Yoshioka; Shinichiro Yamamoto
Journal: J Gastroenterol Date: 2006-05 Impact factor: 7.527

2. A Practical Review of Primary Biliary Cholangitis for the Gastroenterologist.

Authors: Fernanda Q Onofrio; Gideon M Hirschfield; Aliya F Gulamhusein
Journal: Gastroenterol Hepatol (N Y) Date: 2019-03

3. Update on New Drugs and Those in Development for the Treatment of Primary Biliary Cholangitis.

Authors: Runalia Bahar; Kimberly A Wong; Chung H Liu; Christopher L Bowlus
Journal: Gastroenterol Hepatol (N Y) Date: 2018-03

4. Biochemical responses to bezafibrate improve long-term outcome in asymptomatic patients with primary biliary cirrhosis refractory to UDCA.

Authors: Atsushi Tanaka; Junko Hirohara; Yasuni Nakanuma; Hirohito Tsubouchi; Hajime Takikawa
Journal: J Gastroenterol Date: 2014-09-20 Impact factor: 7.527

Review 5. New therapies for primary biliary cirrhosis.

Authors: Annarosa Floreani; Irene Franceschet; Lisa Perini; Nora Cazzagon; M Eric Gershwin; Christopher L Bowlus
Journal: Clin Rev Allergy Immunol Date: 2015-06 Impact factor: 8.667

Review 6. Proposed therapies in primary biliary cholangitis.

Authors: Annarosa Floreani; Ying Sun; Zheng Sheng Zou; Baosen Li; Nora Cazzagon; Christopher L Bowlus; M Eric Gershwin
Journal: Expert Rev Gastroenterol Hepatol Date: 2016-01-06 Impact factor: 3.869

7. Fenofibrate in primary biliary cirrhosis: a pilot study.

Authors: E N Liberopoulos; M Florentin; M S Elisaf; D P Mikhailidis; E Tsianos
Journal: Open Cardiovasc Med J Date: 2010-04-28

Review 8. Nuclear receptors as therapeutic targets in cholestatic liver diseases.

Authors: Gernot Zollner; Michael Trauner
Journal: Br J Pharmacol Date: 2009-01 Impact factor: 8.739

9. Fibrates as adjuvant therapy for chronic cholestatic liver disease: its time has come.

Authors: Nisanne S Ghonem; James L Boyer
Journal: Hepatology Date: 2013-04-05 Impact factor: 17.425

10. Effects of Bezafibrate on Outcome and Pruritus in Primary Biliary Cholangitis With Suboptimal Ursodeoxycholic Acid Response.

Authors: Anna Reig; Pilar Sesé; Albert Parés
Journal: Am J Gastroenterol Date: 2017-10-10 Impact factor: 10.864